BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Del Bello A, Congy-Jolivet N, Danjoux M, Muscari F, Lavayssière L, Esposito L, Hebral AL, Bellière J, Kamar N. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol 2018; 24(16): 1795-1802 [PMID: 29713132 DOI: 10.3748/wjg.v24.i16.1795]
URL: https://www.wjgnet.com/1007-9327/full/v24/i16/1795.htm
Number Citing Articles
1
Mercè Brunet, Teun van Gelder, Anders Åsberg, Vincent Haufroid, Dennis A. Hesselink, Loralie Langman, Florian Lemaitre, Pierre Marquet, Christoph Seger, Maria Shipkova, Alexander Vinks, Pierre Wallemacq, Eberhard Wieland, Jean Baptiste Woillard, Markus J. Barten, Klemens Budde, Helena Colom, Maja-Theresa Dieterlen, Laure Elens, Kamisha L. Johnson-Davis, Paweł K. Kunicki, Iain MacPhee, Satohiro Masuda, Binu S. Mathew, Olga Millán, Tomoyuki Mizuno, Dirk-Jan A. R. Moes, Caroline Monchaud, Ofelia Noceti, Tomasz Pawinski, Nicolas Picard, Ron van Schaik, Claudia Sommerer, Nils Tore Vethe, Brenda de Winter, Uwe Christians, Stein Bergan. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportTherapeutic Drug Monitoring 2019; 41(3): 261 doi: 10.1097/FTD.0000000000000640
2
Caner Süsal, Bernd Döhler. Late intra‐patient tacrolimus trough level variability as a major problem in kidney transplantation: A Collaborative Transplant Study ReportAmerican Journal of Transplantation 2019; 19(10): 2805 doi: 10.1111/ajt.15346
3
Julien Vionnet, Christine Sempoux, Manuel Pascual, Alberto Sánchez-Fueyo, Jordi Colmenero. Donor-specific antibodies in liver transplantationGastroenterología y Hepatología 2020; 43(1): 34 doi: 10.1016/j.gastrohep.2019.09.010
4
Ariel Kenig, Yotam Kolben, Rabea Asleh, Offer Amir, Yaron Ilan. Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided AlgorithmFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.695547
5
Caner Süsal, Güclü Aykut, Christian Morath, Alexander Fichtner, Christian Unterrainer, Sabine Scherer, Thuong H. Tran, Arianeb Mehrabi, Martin Zeier, Burkhard Tönshoff. Relevance of donor‐specific antibody monitoring after kidney transplantation: Findings from the Collaborative Transplant Study and the Heidelberg Transplant CenterHLA 2019; 94(S2): 11 doi: 10.1111/tan.13665
6
Tawfik Khoury, Yaron Ilan. Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF TherapiesFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02726
7
Yamei Li, Lin Yan, Yi Li, Zhengli Wan, Yangjuan Bai, Xianding Wang, Shumeng Hu, Xiaojuan Wu, Cuili Yang, Jiwen Fan, Huan Xu, Lanlan Wang, Yunying Shi. Development and validation of routine clinical laboratory data derived marker-based nomograms for the prediction of 5-year graft survival in kidney transplant recipientsAging 2021; 13(7): 9927 doi: 10.18632/aging.202748
8
Rongrong Wang, Weili Wang, Kuifen Ma, Xin Duan, Fangfang Wang, Mingzhu Huang, Wei Zhang, Tingbo Liang. Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational StudyFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01252
9
Sasha Deutsch‐Link, Ethan M. Weinberg, Therese Bittermann, Mackenzie McDougal, Aniket Dhariwal, Lauren S. Jones, Robert M. Weinrieb, Arpita G. Banerjee, Senayish Addis, Marina Serper. The Stanford Integrated Psychosocial Assessment for Transplant Is Associated With Outcomes Before and After Liver TransplantationLiver Transplantation 2021; 27(5): 652 doi: 10.1002/lt.25975
10
Daryl U. Nnani, Alesa Campbell, Maria Ajaimy, Omar Saeed, Snehal R. Patel, Sana Ahmed, Jay A. Graham, Ulrich P. Jorde. Effect of glecaprevir/pibrentasvir on weight‐adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipientsTransplant Infectious Disease 2021;  doi: 10.1111/tid.13716
11
Arnaud Del Bello, Clotilde Gaible, Nathalie Longlune, Anne-Laure Hebral, Laure Esposito, Peggy Gandia, Nassim Kamar. Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ TransplantationFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.602764
12
Steven C. Kim, David P. Foley. Donor-specific antibodies in liver transplantation: challenges in diagnosis and determining clinical impactCurrent Opinion in Organ Transplantation 2020; 25(6): 549 doi: 10.1097/MOT.0000000000000825
13
Jérôme Dumortier, Camille Besch, Lucile Moga, Audrey Coilly, Filomena Conti, Christophe Corpechot, Arnaud Del Bello, François Faitot, Claire Francoz, Marie-Noëlle Hilleret, Pauline Houssel-Debry, Caroline Jezequel, Laurence Lavayssière, Martine Neau-Cransac, Domitille Erard-Poinsot, Victor de Lédinghen, Marc Bourlière, Christophe Bureau, Nathalie Ganne-Carrié. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP IN LIVER TRANSPLANTATIONClinics and Research in Hepatology and Gastroenterology 2021; : 101774 doi: 10.1016/j.clinre.2021.101774
14
Nobuhiro Fujiyama, Shigeru Satoh, Mitsuru Saito, Kazuyuki Numakura, Takamitsu Inoue, Ryohei Yamamoto, Takuro Saito, Taketoshi Nara, Sohei Kanda, Shintaro Narita, Hideaki Kagaya, Masatomo Miura, Tomonori Habuchi. Association of immunosuppressive agents and cytomegalovirus infection with de novo donor-specific antibody development within 1 year after renal transplantationInternational Immunopharmacology 2019; 76: 105881 doi: 10.1016/j.intimp.2019.105881
15
Hyunmin Ko, Hyo Kee Kim, Chris Chung, Ahram Han, Seung-Kee Min, Jongwon Ha, Sangil Min. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipientsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84868-5
16
Suwasin Udomkarnjananun, Marith I. Francke, Brenda C.M. De Winter, Midas B. Mulder, Carla C. Baan, Herold J. Metselaar, Caroline M. den Hoed, Dennis A. Hesselink. Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterologyBest Practice & Research Clinical Gastroenterology 2021; : 101756 doi: 10.1016/j.bpg.2021.101756
17
Taisa J. Kohut, Jose F. Barandiaran, Brendan J. Keating. Genomics and Liver Transplantation: Genomic Biomarkers for the Diagnosis of Acute Cellular RejectionLiver Transplantation 2020; 26(10): 1337 doi: 10.1002/lt.25812
18
Yaron Ilan. Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical OutcomesFrontiers in Digital Health 2020; 2 doi: 10.3389/fdgth.2020.569178
19
Françoise Smets. Pediatric Liver Transplantation2021; : 157 doi: 10.1016/B978-0-323-63671-1.00018-5
20
Aleixandra Mendoza Rojas, Dennis A. Hesselink, Nicole M. van Besouw, Carla C. Baan, Teun van Gelder. Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipientsExpert Review of Clinical Immunology 2019; 15(12): 1323 doi: 10.1080/1744666X.2020.1693263
21
Teun Gelder. A new method to calculate intra‐patient variability in tacrolimus concentrationsBritish Journal of Clinical Pharmacology 2021;  doi: 10.1111/bcp.14865
22
Sasha Deutsch-Link, Robert M. Weinrieb, Lauren S. Jones, Steven F. Solga, Ethan M. Weinberg, Marina Serper. Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver TransplantationDigestive Diseases and Sciences 2020; 65(7): 2089 doi: 10.1007/s10620-019-05937-4
23
Abbie D. Leino, Manjunath P. Pai. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose SelectionClinical Pharmacokinetics 2020; 59(11): 1317 doi: 10.1007/s40262-020-00923-w
24
Yuval Ishay, Assaf Potruch, Asaf Schwartz, Marc Berg, Khurram Jamil, Samuel Agus, Yaron Ilan. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damageBiomedicine & Pharmacotherapy 2021; 143: 112228 doi: 10.1016/j.biopha.2021.112228
25
Yaron Ilan, Zachary Spigelman. Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistanceCancer Treatment and Research Communications 2020; 25: 100240 doi: 10.1016/j.ctarc.2020.100240
26
Laura J. Wozniak, Robert S. Venick. Donor-specific antibodies following liver and intestinal transplantation: Clinical significance, pathogenesis and recommendationsInternational Reviews of Immunology 2019; 38(3): 106 doi: 10.1080/08830185.2019.1630404
27
Eyal Shemesh. Using Medication Level Variability to Predict Posttransplant RiskLiver Transplantation 2021; 27(6): 936 doi: 10.1002/lt.26012
28
Julien Vionnet, Christine Sempoux, Manuel Pascual, Alberto Sánchez-Fueyo, Jordi Colmenero. Donor-specific antibodies in liver transplantationGastroenterología y Hepatología (English Edition) 2020; 43(1): 34 doi: 10.1016/j.gastre.2019.09.004
29
Jordana Herblum, Niki Dacouris, Michael Huang, Jeffrey Zaltzman, G. V. Ramesh Prasad, Michelle Nash, Lucy Chen. Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication AdherenceCanadian Journal of Kidney Health and Disease 2021; 8: 205435812110217 doi: 10.1177/20543581211021742
30
Nuttasith Larpparisuth, Tanapon Pongnatcha, Pera Panprom, Ratchawat Promraj, Nalinee Premasathian, Attapong Vongwiwatana. High Intrapatient Variability in Tacrolimus Exposure Calculated Over a Long Period Is Associated With De Novo Donor-Specific Antibody Development and/or Late Rejection in Thai Kidney Transplant Patients Receiving Concomitant CYP3A4/5 InhibitorsTherapeutic Drug Monitoring 2021; 43(5): 624 doi: 10.1097/FTD.0000000000000850
31
Dirk R.J. Kuypers. Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical OutcomeClinical Pharmacology & Therapeutics 2020; 107(2): 347 doi: 10.1002/cpt.1618
32
Lauren Schumacher, Abbie D. Leino, Jeong M. Park. Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspectivePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(1): 103 doi: 10.1002/phar.2480
33
Assaf Potruch, Salim T. Khoury, Yaron Ilan. The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugsSeizure 2020; 80: 201 doi: 10.1016/j.seizure.2020.06.032
34
David Choi, Sarang Thaker, Patricia West-Thielke, Annesti Elmasri, Christine Chan. Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipientsEuropean Journal of Gastroenterology & Hepatology 2021; 33(8): 1124 doi: 10.1097/MEG.0000000000002172
35
Jessica Katharine Strong, Petra Gaylard, Heather Maher, Jean Botha. Acute Cellular Rejection in Paediatric Liver Transplants: Does a Living Donor Ameliorate the Risk of Rejection in Our Patients? A Retrospective Review at Wits Donald Gordon Medical Centre, South AfricaWits Journal of Clinical Medicine 2019; 1(3): 10 doi: 10.18772/26180197.2019.v1n3a1
36
Charat Thongprayoon, Panupong Hansrivijit, Karthik Kovvuru, Swetha R. Kanduri, Tarun Bathini, Aleksandra Pivovarova, Justin R. Smith, Wisit Cheungpasitporn. Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant RecipientsJournal of Clinical Medicine 2020; 9(7): 2193 doi: 10.3390/jcm9072193